4/A: Syra Health CEO Receives Stock Grant
Insider Transaction (Form 4/A)
Gregory R. Alexander, CEO of Syra Health Corp, reported multiple transactions in common stock on January 5, 2026.
Summary
- Grant/award: acquired 110,537 Restricted Stock Units on January 5, 2026; holds 110,537 after (Direct).
- Grant/award: acquired 257,920 Stock Options on January 5, 2026; holds 257,920 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Gregory R. Alexander — Officer (CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-01-05 | Grant/award | Restricted Stock Units | 110,537 | — | — | 110,537 |
| 2026-01-05 | Grant/award | Stock Options | 257,920 | — | — | 257,920 |
Key Dates
| Date | Description |
|---|---|
| 2026-01-05 | Grant/award (110,537 shares) |
| 2026-01-05 | Grant/award (257,920 shares) |
Keywords
insider transaction, Form 4/A, SYRA, Syra Health Corp, neutral, Gregory R. Alexander
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.